Briana Schell, MS ED, CCC-SLP | |
245 La Cuesta Cir, Yona, GU 96915-6009 | |
(671) 788-8971 | |
Not Available |
Full Name | Briana Schell |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 245 La Cuesta Cir, Yona, Guam |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073012001 | NPI | - | NPPES |
SLA-071 | Other | GU | GUAM BOARD OF ALLIED HEALTH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SLA-071 (Guam) | Primary |
Mailing Address | Practice Location Address |
---|---|
Briana Schell, MS ED, CCC-SLP 245 La Cuesta Cir, Yona, GU 96915-6009 Ph: () - | Briana Schell, MS ED, CCC-SLP 245 La Cuesta Cir, Yona, GU 96915-6009 Ph: (671) 788-8971 |
News Archive
Members of a Senate committee expressed concern Wednesday that reforms taken by the departments of Defense and Veterans Affairs have done little to cut the maze of bureaucracy experienced by many service members and veterans trying to navigate the military health-care system.
Novartis is highlighting new research from members of the faculty at the University of Pennsylvania's Perelman School of Medicine on the investigational chimeric antigen receptor therapy, CTL019. Several studies being presented at the American Society of Hematology annual meeting add to the scientific understanding of CTL019 in the treatment of acute lymphoblastic leukemia and chronic lymphocytic leukemia and build on earlier research findings.
Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
› Verified 6 days ago